Amikacin and colistin for treatment of Acinetobacter baumannii meningitis

Eric J. Fulnecky, Donald Wright, W. Michael Scheld, Lama Kanawati, Shmuel Shoham

Research output: Contribution to journalArticle


We report a case of a 52-year-old man with post-surgical meningitis due to a multi-drug resistant Acinetobacter baumannii. Despite therapy with intravenous amikacin and imipenem the meningitis progressed. Upon institution of combination therapy with amikacin by the intravenous and intrathecal (IT) routes, and intravenous colistin the patient experienced successful clinical and microbiological outcomes.

Original languageEnglish (US)
JournalJournal of Infection
Issue number5
Publication statusPublished - Dec 2005
Externally publishedYes



  • Acinetobacter baumannii
  • Amikacin
  • Colistin
  • Intrathecal
  • Meningitis

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Microbiology
  • Parasitology
  • Virology
  • Immunology and Allergy
  • Infectious Diseases

Cite this